AC
SBCWW

Aristeia Capital’s SBC Medical Group Warrants SBCWW Stock Holding History

Aristeia Capital’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Hold
530,169
– – ﹤0.01% 590
2026
Q1 		$159K Buy
530,169
+208
+0% +$59 ﹤0.01% 484
2025
Q4 		$122K Buy
529,961
+187,234
+55% +$32.2K ﹤0.01% 455
2025
Q3 		$74.3K Buy
342,727
+213,483
+165% +$40.1K ﹤0.01% 444
2025
Q2 		$27.9K Sell
129,244
-31,674
-20% -$6.01K ﹤0.01% 437
2025
Q1 		$34.5K Sell
160,918
-19,082
-11% -$4.6K ﹤0.01% 371
2024
Q4 		$44.1K Hold
180,000
– – ﹤0.01% 317
2024
Q3 		$26.8K Hold
180,000
– – ﹤0.01% 291
2024
Q2 		$14.1K Hold
180,000
– – ﹤0.01% 292
2024
Q1 		$6.04K Hold
180,000
– – ﹤0.01% 280
2023
Q4 		$6.13K Hold
180,000
– – ﹤0.01% 197
2023
Q3 		$8.55K Hold
180,000
– – ﹤0.01% 221
2023
Q2 		$10.1K Hold
180,000
– – ﹤0.01% 234
2023
Q1 		$9.67K Hold
180,000
– – ﹤0.01% 358
2022
Q4 		$9.93K Hold
180,000
– – ﹤0.01% 455
2022
Q3 		$18K Buy
+180,000
New +$15K ﹤0.01% 594

Other funds holding SBCWW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Aristeia Capital's SBCWW Position: Q2 2026 in Review

Aristeia Capital held its SBC Medical Group Warrants (SBCWW) position steady in Q2 2026 at 530,169 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Aristeia Capital first reported a position in SBCWW in Q3 2022 and has held it in 16 quarters since. The position peaked at $159K in Q1 2026. 17 funds tracked by Wall St. Rank hold SBCWW as of Q2 2026.

  • Aristeia Capital held 530,169 shares of SBC Medical Group Warrants worth $135K as of Q2 2026.
  • Aristeia Capital left its SBC Medical Group Warrants share count unchanged in Q2 2026.
  • SBC Medical Group Warrants made up ﹤0.01% of Aristeia Capital's portfolio in Q2 2026, its #590 holding.
  • Aristeia Capital first reported a position in SBC Medical Group Warrants in Q3 2022 and has held it in 16 quarters since.
  • Aristeia Capital's SBC Medical Group Warrants position peaked at $159K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.